PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a proof-of-concept study to determine if PH-797804 reduces neuropathic pain
associated with post-herpetic neuralgia. Suitable patients will be randomized to receive
either PH-797804 or placebo for 4 weeks, during which time they will also record their pain
symptoms using various pain scales.